Overall, there is evidence of impaired B cell function after SARS-CoV-2 infection and aberrant expression of major B cell markers, e.g., in patients after severe COVID-19 who experienced downregulated B cell CD19 expression 1 year later (88), which may affect B cell activation upon antigen recognition. This evidence concerns the gene CD19 and COVID-19.